American Society for Pharmacology & Experimental Therapeutics: Our members conduct research that develops disease-fighting medicines and therapeutic agents.
We talked with Dr. Chloe Kirk (aka Chloe the Scientist) about Science Communications, what advice she offers scientists on furthering their voice and reach, her particular path from the lab to the camera, and much more.
🔗 Meet Chloe the Scientist: thepharmacologist.org/chloe-…!
Ben Clements, PhD, a Postdoctoral Research Fellow, is the JPET HTA for June 2026. His research focuses on the characterization of novel pain therapeutics, ranging from NMDA receptor antagonists to opioid receptor allosteric modulators.
🔗 doi.org/10.1016/j.jpet.2026.…
The data in JPET's recent Editor's Choice suggests inhibitors that target the SOX11 DNA-binding domain may be effective in neuroendocrine prostate cancer, providing hope that the most aggressive prostate cancer can be treated. Read the research: ow.ly/HJOT50Z9Syc
From the lab to the feed: Dr. Chloe Kirk (aka Chloe the Scientist) has built a major platform by making science more engaging. She discusses her path to science communication and shares how scientists can use social media to further their voice: thepharmacologist.org/chloe-…
The ASPET's Great Lakes Conference is this Friday, and TODAY is the last day to register! Make sure you sign up and take advantage of this opportunity to participate and engage in productive discussions with colleagues in the field: ow.ly/MTBl50Z89Is
If you are a graduate student, postdoc, or early career investigator and are interested in science policy and advocacy or a potential career in policy, then the Washington Fellows Program is for you!
đź“… Applications Due: June 30
🔗 aspet.org/aspet/advocacy/asp…
Join us for this live lecture from distinguished scientist, and winner of the 2026 Otto Krayer Award, Joseph Coyle, MD! His presentation will be open to both ASPET members and non-members.
Learn more and register: ow.ly/AJ6750Z4OUp
Interested in learning more about "Advances in GLP-1 Pharmacology: Obesity and Beyond?" Join the Great Lakes Chapter (GLC) of ASPET for their 39th Annual Scientific Meeting on June 12 at Midwestern University in Downers Grove: ow.ly/E4Va50Z7HMc
Submit your research to JPET's special collection, “Multi-Systems Pharmacology and Therapeutic Application of Adipokines and Neuropeptides in Obesity.” Original research articles or minireviews will be considered. Learn more about this opportunity: ow.ly/cM2t50Z6In1
Check out the featured article in Drug Metabolism and Disposition's most recent issue, free to read and share with your colleagues for a limited time: ow.ly/Qhm950Z7ffb
Dave Jackson discusses ASPET’s plans for the summer following the 2026 Annual Conference, including the Awardee Lecture Series, the Focus on Pharmacology webinars, ASPET’s attendance at the upcoming World Congress of Pharmacology, and more: ow.ly/PvqP50Z5KbY
What happens when 1000 passionate scientists and researchers come together at the pharmacology event of the year? New ideas are sparked, connections are made, and our community grows stronger. Take a look back at the highlights and memories that made #ASPET2026 unforgettable. đź§Ş
Read JPET's recent Editor's Choice, which gives hope that a novel treatment may come to fruition to help our endogenous T cells target cancer: ow.ly/QQvM50Z6GvR
Send in your research to this special collection covering key areas of GPCR research. The collection will include original research articles and a limited number of commentaries and consideration for minireviews: ow.ly/pIoq50Z6jYg
ASPET was on Capitol Hill today with the Coalition of Health Funding (CHF) speaking with Congress on FY2027 appropriations issues including maintaining a consistent and robust funding stream, having grants funded, and other issues impacting NIH.
Thomas Lamme, a PhD Candidate, is the Molecular Pharmacology HTA for June 2026. His research focuses on how immune cells are guided towards the gut through a chemical navigation system involving CCL25 and its receptors CCR9 and ACKR4: doi.org/10.1016/j.molpha.202….
Randy Hall, PhD, discusses the shift of public trust in scientists, which has fallen sharply since the COVID-19 pandemic, and shares how effective communication by scientists and social media are essential: thepharmacologist.org/messag…
Steer the future of pharmacology and toxicology! ASPET's influential journal, Drug Metabolism and Disposition, is seeking a new Editor-in-Chief, and the deadline to apply is June 1! Learn more and apply: ow.ly/yt0a50Z4naA
Have you submitted your research to ASPET Discovery? This Gold Open Access journal covers a variety of areas in pharmacology, and its diverse editorial board ensures the presentation of rigorous, sound science. Learn why we're perfect for your work: ow.ly/hQia50Z4osN